Hantavirus myths vs facts: What you should know

Public health guidance is taking centre stage as health authorities move to debunk widespread misconceptions surrounding Hantavirus.

Far from a novel threat, the pathogen is a well-documented group of viruses primarily transmitted to humans through direct contact with infected rodents. Ensuring the public understands the exact nature of transmission and treatment remains vital to preventing unnecessary panic.

A primary area of confusion involves how the virus spreads. Despite fears that it behaves like highly contagious respiratory illnesses, human-to-human transmission of Hantavirus is exceptionally rare, typically requiring close, prolonged indoor contact.

Additionally, health officials emphasise that this is not a new virus, as rodent-borne strains have been actively tracked for decades.

Misinformation regarding pharmaceutical interventions also persists. Medical data confirms that Ivermectin does not cure Hantavirus, with the World Health Organisation stating there is no evidence to support its efficacy.

Similarly, because Hantavirus is entirely viral, antibiotics are completely ineffective unless a secondary bacterial infection occurs.

While no approved antiviral drug currently exists for the pathogen, an infection is by no means an automatic death sentence. Early supportive clinical care significantly improves patient survival rates.

To manage potential clusters effectively, standard public health protocols remain the frontline defence. Rather than signalling a hidden crisis, standard implementation of monitoring, rigorous contact tracing, and targeted isolation measures is a vital, proactive tool designed to detect cases early and strictly limit any further spread.